Statistics

Total Visits

Views
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study126

Select a period of time:

Number of views in the range

Views
Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study26

Views

Views
November 20250
December 20256
January 20261
February 20262
March 202612
April 20263
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Brazil2
Germany2
Argentina2
Chile1
United Kingdom1
Netherlands1
Singapore1
Turkey1
Venezuela1
 

Top cities views

Views
Santa Clara2
Frankfurt am Main2
Amsterdam1
Buffalo1
Buin1
Columbus1
Durban1
Istanbul1
João Monlevade1
Los Angeles1